# Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

> **NCT03915340** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 32 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Propafenone
- **DRUG:** Rytmonorm

## Key facts

- **NCT ID:** NCT03915340
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-23
- **Primary completion:** 2019-05-08
- **Final completion:** 2019-05-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03915340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03915340, "Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03915340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*